Showing results (411-420 of 574) with videos related to
Sort By:
Pageof 58
Cancer|April 1, 1981
Serum zinc levels in lung cancer patientsB F Issell, B V MacFadyen, E T Gum, et al.Science (New York, N.Y.)|September 22, 1972
Antigen solubilized from human leukemia: lymphocyte stimulationJ U Gutterman, G Mavligit, K B McCredie, et al.American Journal of Clinical Oncology|August 1, 1982
Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosoureaJ R Stroehlein, A Y Bedikian, D A Karlin, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetics and metabolism of beta-2'-deoxythioguanosine and 6-thioguanine in manK Lu, J A Benvenuto, G P Bodey, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 1998
Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancerG Samonis, P Skordilis, S Maraki, et al.American Journal of Clinical Oncology|August 1, 1984
Phase II evaluation of PALA in patients with refractory metastatic sarcomasR Kurzrock, B S Yap, C Plager, et al.Cancer|January 1, 1984
Carminomycin. A new anthracycline analog in the treatment of advanced breast cancerA Aboud, H Y Yap, L Esparza, et al.The Journal of Infectious Diseases|July 1, 1991
Effect of subinhibitory concentrations of clindamycin and trospectomycin on the adherence of Staphylococcus epidermidis in an in vitro model of vascular catheter colonizationN Khardori, E Wong, H Nguyen, et al.Cancer Treatment Reports|September 1, 1981
Chemotherapy for colorectal cancer with a combination of PALA and 5-FUA Y Bedikian, J R Stroehlein, D A Karlin, et al.Cancer Treatment Reports|September 1, 1981
Vindesine in the treatment of refractory breast cancer: improvement in therapeutic index with continuous 5-day infusionH Y Yap, G R Blumenschein, G P Bodey, et al.Pageof 58